Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Rubenstein

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Investigative Dermatology|October 12, 2007
Induction of p38MAPK and HSP27 phosphorylation in pemphigus patient skinPaula Berkowitz, Luis A Diaz, Russel P Hall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 2, 2010
Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodiesVolker Spindler, Franziska Vielmuth, Enno Schmidt, et al.
The American Journal of Pathology|November 8, 2008
Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skinPaula Berkowitz, Michael Chua, Zhi Liu, et al.
Pediatric Dermatology|December 16, 2005
Pediatric Sweet syndrome and immunodeficiency successfully treated with intravenous immunoglobulinElena Haliasos, Bradley Soder, David S Rubenstein, et al.
The Journal of Biological Chemistry|February 14, 2013
A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysisMeryem Bektas, Puneet S Jolly, Paula Berkowitz, et al.
Journal of the American Academy of Dermatology|June 10, 2021
Tapinarof cream 1% once daily and benvitimod 1% twice daily are 2 distinct topical medicationsLinda Stein Gold, David S Rubenstein, Ken Peist, et al.
Journal of the American Academy of Dermatology|November 6, 2020
Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agentRobert Bissonnette, Linda Stein Gold, David S Rubenstein, et al.
Journal of the American Academy of Dermatology|March 7, 2021
Tapinarof-associated folliculitis is generally mild, self-limiting, and rarely interferes with therapyRobert Bissonnette, Linda Stein Gold, David S Rubenstein, et al.
Journal of the American Academy of Dermatology|March 7, 2021
The preponderance of evidence supports an aryl hydrocarbon receptor-dependent mechanism of action of tapinarofRobert Bissonnette, Linda Stein Gold, David S Rubenstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2006
p38MAPK inhibition prevents disease in pemphigus vulgaris micePaula Berkowitz, Peiqi Hu, Simon Warren, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Investigative Dermatology|October 12, 2007
Induction of p38MAPK and HSP27 phosphorylation in pemphigus patient skinPaula Berkowitz, Luis A Diaz, Russel P Hall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 2, 2010
Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodiesVolker Spindler, Franziska Vielmuth, Enno Schmidt, et al.
The American Journal of Pathology|November 8, 2008
Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skinPaula Berkowitz, Michael Chua, Zhi Liu, et al.
Pediatric Dermatology|December 16, 2005
Pediatric Sweet syndrome and immunodeficiency successfully treated with intravenous immunoglobulinElena Haliasos, Bradley Soder, David S Rubenstein, et al.
The Journal of Biological Chemistry|February 14, 2013
A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysisMeryem Bektas, Puneet S Jolly, Paula Berkowitz, et al.
Journal of the American Academy of Dermatology|June 10, 2021
Tapinarof cream 1% once daily and benvitimod 1% twice daily are 2 distinct topical medicationsLinda Stein Gold, David S Rubenstein, Ken Peist, et al.
Journal of the American Academy of Dermatology|November 6, 2020
Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agentRobert Bissonnette, Linda Stein Gold, David S Rubenstein, et al.
Journal of the American Academy of Dermatology|March 7, 2021
Tapinarof-associated folliculitis is generally mild, self-limiting, and rarely interferes with therapyRobert Bissonnette, Linda Stein Gold, David S Rubenstein, et al.
Journal of the American Academy of Dermatology|March 7, 2021
The preponderance of evidence supports an aryl hydrocarbon receptor-dependent mechanism of action of tapinarofRobert Bissonnette, Linda Stein Gold, David S Rubenstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2006
p38MAPK inhibition prevents disease in pemphigus vulgaris micePaula Berkowitz, Peiqi Hu, Simon Warren, et al.
Pageof 6